Lalit Mohan Nainwal is a dedicated and highly qualified pharmaceutical researcher pursuing a PhD in Pharmaceutical Chemistry at Jamia Hamdard, Delhi (since 2016). With a strong academic foundation including an M.Pharm (Pharmaceutical Chemistry) from Dibrugarh University, he possesses excellent conceptual knowledge in Pharmaceutical Chemistry, Pharmacology, and Pharmaceutics.His research experience includes a role as a Junior Research Fellow (JRF) at CEPS, Guru Gobind Singh Indraprastha University (2014-2017). He has significant expertise in In-silico Drug Design (using software like Vlife, AUTODOCK, pyMOL), Microwave-Assisted Synthesis, and various instrumental techniques (HPLC, FT-IR, UV-Vis).He has a solid publication record in national and international journals (including multiple SCI journals with IF up to 2.73) focusing on Anticancer and Antidiabetic agents, particularly the design and docking of novel compounds. He is GPAT qualified (All India Rank 1417) and seeks a challenging environment for continuous professional growth.
Editorial Board Member
Dr. Lalit Mohan Nainwal
Research Interests :
Introduction
AFFILIATION
Junior Research
Chemistry
Guru Gobind Singh Indraprastha University
Guru Gobind Singh Indraprastha University Sector 16-C, Dwarka, New Delhi-110078 (INDIA)
NEW DELHI
India
110078
Email : lalit12331@yahoo.com
RESEARCH IDS
| # | ID Type |
|---|---|
| 1. | ORCiD |
RESEARCH INTERESTS
| # | Area |
|---|---|
| 1. | Anticancer |
| 2. | Antimalarial |
| 3. | Drug Design and Development |
PAPERS PUBLISHED
| # | Article Title | Year |
|---|---|---|
| 1. | Julfikar Ali Junejo, Mithun Rudrapal, Lalit Mohan Nainwal, and Kamaruz Zaman. "Antidiabetic activity of hydro-alcoholic stem bark extract of Callicarpa arborea Roxb. with antioxidant potential in diabetic rats." Biomedicine & Pharmacotherapy 95 (2017): 84-94. (SCI, IF- 2.73) | 2017 |
| 2. | Partha Sarathi Bairy, Aparoop Das, Lalit Mohan Nainwal, Tapan Kumar Mohanta, Mukesh Kumar Kumawat, Pradyumna Kishore Mohapatra, and Pratap Parida. "Design, synthesis and anti-diabetic activity of some novel xanthone derivatives targeting α-glucosidase." Bangladesh Journal of Pharmacology 11, no. 2 (2016): 308-318. (SCI, IF- 0.6) | 2016 |
| 3. | Partha Sarathi Bairy, Nilutpal Sharma Bora, Bibhuti Bhusan Kakoti, Aparoop Das, Lalit Mohan Nainwal, and Barnali Gogoi. "Preliminary phytochemical screening, in vitro antioxidant activity, total polyphenolic and flavonoid content of Garcinia lanceifolia Roxb. and Citrus maxima (Burm.) Merr." Journal of Applied Pharmaceutical Science 6 (9) (2016): 133-139 | 2016 |
| 4. | Sharma, Hemanta Kumar, Barnali Gogoi, and Lalit Mohan Nainwal. "A Review on Some Antioxidant Plant Species Growing in North East India." International Journal of Pharmaceutical Sciences Review and Research 37(1) (2016): 224-229 | 2016 |
| 5. | Lalit Mohan Nainwal, Pratap Parida, Aparoop Das, and Parth Sarathi Bairy. "Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha." Bangladesh Journal of Pharmacology 9, no. 2 (2014): 208-217. (SCI, IF- 0.6) | 2014 |
| 6. | Lakhyajit Boruah, Aparoop Das, Lalit Mohan Nainwal, Neha Agarwal, and Brajesh Shankar. "In-Silico Drug Design: A revolutionary approach to change the concept of current Drug Discovery Process." Indian Journal of Pharmaceutical & Biological Research 1 (2013): 60-73. akhyajit Boruah, Aparoop Das, Lalit Mohan Nainwal, Neha Agarwal, and Brajesh Shankar. "In-Silico Drug Design: A revolutionary approach to change the concept of current Drug Discovery Process." Indian Journal of Pharmaceutical & Biological Research 1 (2013): 60-73. | 2013 |
| 7. | Parida, Pratap, R. N. S. Yadav, Kishore Sarma, and Lalit Mohan Nainwal. "Design, virtual screening and docking study of novel NS3 inhibitors by targeting protein-protein interacting sites of dengue virus-a novel approach." Current pharmaceutical biotechnology 14, no 11, (2013): 995-1008. (SCI, IF- 2.4 | 2013 |
| 8. | Aparoop Das, Krishna Debnath, Partha Sarathi Bairy and Lalit Nainwal. Synthesis and antimicrobial screening of a series of 3,6-bis(3'-substitutedpropoxy)xanthone & 3,6-bis(5'-substituted pentyloxy)xanthone derivatives. Current Trends in Pharmaceutical Research. 2(1) (2013): 13-23. | 2013 |
| 9. | Yogesh Singh, Jainendra Jain, Partha Chowdhury, Lalit Nainwal. Study of halogen substituent on docking and 3D QSAR properties of aryl substituted thiosemicarbazones as anticonvulsant. International Journal of Therapeutic Applications 6 (2012): 1-7. | 2012 |
BOOKS PUBLISHED
| # | Title | Publication Year |
|---|
BOOK CHAPTERS PUBLISHED
| # | Chapter Title | Book Title | Publication Year |
|---|
ACADEMIC PROFILE
| # | Examination | Passing Year | Country |
|---|---|---|---|
| 1. | Perusing PhD | 2016 | India |
| 2. | M. Pharm | 2014 | India |
| 3. | D. Pharm | 2009 | India |
| 4. | 12th | 2007 | India |
| 5. | 10th | 2005 | India |
EMPLOYMENT DETAILS
| # | Institution | Position | Country | Service Period |
|---|---|---|---|---|
| 1. | Guru Gobind Singh Indrprastha University | Junior Research Fellow | India | 2 years, 3 months, 0 days |
| 2. | Sir Ganga Ram Hospital, Karol Bagh | Intern | India | 0 years, 3 months, 0 days |
| Total Period : | 2 years, 6 months, 0 days |
PAPERS PRESENTED IN CONFERENCES
RESEARCH PROJECTS
MEMBERSHIPS
TRAINING PROGRAMS ATTENDED
HONOURS AWARDS AND DISTINCTIONS
EVENTS ATTENDED
EVENTS ORGANIZED